{"id":"https://openalex.org/W2319434591","doi":"https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4455","title":"Assessment Of Safety And Pharmacokinetic Profile Of A Novel Fixed Combination Of Glycopyrrolate And Formoterol HFA MDI In Healthy Volunteers","display_name":"Assessment Of Safety And Pharmacokinetic Profile Of A Novel Fixed Combination Of Glycopyrrolate And Formoterol HFA MDI In Healthy Volunteers","publication_year":2010,"publication_date":"2010-05-01","ids":{"openalex":"https://openalex.org/W2319434591","doi":"https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4455","mag":"2319434591"},"language":"en","primary_location":{"id":"doi:10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4455","doi":"https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4455","is_oa":false,"landing_page_url":"https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4455","pdf_url":null,"source":{"id":"https://openalex.org/S93356601","display_name":"American Journal of Respiratory and Critical Care Medicine","issn_l":"1073-449X","issn":["1073-449X","1535-4970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316311","host_organization_name":"American Thoracic Society","host_organization_lineage":["https://openalex.org/P4310316311"],"host_organization_lineage_names":["American Thoracic Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"C41. EMERGING PHARMACOLOGY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: MECHANISMS AND OUTCOMES","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021649243","display_name":"Joanne K. Marjason","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joanne Marjason","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108216749","display_name":"Chadwick J. Orevillo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chadwick J. Orevillo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101579066","display_name":"Earl St. Rose","orcid":"https://orcid.org/0000-0001-7269-437X","observed_orcids":["https://orcid.org/0000-0001-7269-437X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Earl St Rose","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070315113","display_name":"Gary T. Ferguson","orcid":"https://orcid.org/0000-0002-3277-4110","observed_orcids":["https://orcid.org/0000-0002-3277-4110"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary T. Ferguson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045378562","display_name":"Reinhard Vehring","orcid":"https://orcid.org/0000-0002-4446-9826","observed_orcids":["https://orcid.org/0000-0002-4446-9826"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reinhard Vehring","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110458450","display_name":"Vidya Joshi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vidya Joshi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004032785","display_name":"Sarvajna Dwivedi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarvajna Dwivedi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5077419098","display_name":"Colin Reisner","orcid":"https://orcid.org/0000-0003-1856-9863","observed_orcids":["https://orcid.org/0000-0003-1856-9863"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colin Reisner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A4455","last_page":"A4455"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glycopyrrolate","display_name":"glycopyrrolate","score":0.9909999966621399},{"id":"https://openalex.org/keywords/formoterol-fumarate","display_name":"formoterol fumarate","score":0.9879999756813049},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.7770000100135803},{"id":"https://openalex.org/keywords/metered-dose-inhaler","display_name":"MDI","score":0.9309999942779541},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8700000047683716},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7960000038146973},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.859000027179718},{"id":"https://openalex.org/keywords/inhaled-anticholinergics","display_name":"inhaled anticholinergics","score":0.6200000047683716},{"id":"https://openalex.org/keywords/inhaled-beta2-agonists","display_name":"inhaled beta2-agonists","score":0.7919999957084656},{"id":"https://openalex.org/keywords/xerostomia","display_name":"xerostomia","score":0.5960000157356262},{"id":"https://openalex.org/keywords/tremor","display_name":"tremor","score":0.9520000219345093},{"id":"https://openalex.org/keywords/serum-potassium","display_name":"serum potassium","score":0.5440000295639038},{"id":"https://openalex.org/keywords/first-in-human","display_name":"first-in-human","score":0.492000013589859}],"concepts":[{"id":"https://openalex.org/C2909581452","wikidata":"https://www.wikidata.org/wiki/Q27162963","display_name":"Glycopyrrolate","level":3,"score":0.85104900598526},{"id":"https://openalex.org/C2779871671","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol","level":4,"score":0.7663102149963379},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6596687436103821},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5047417879104614},{"id":"https://openalex.org/C2776623344","wikidata":"https://www.wikidata.org/wiki/Q5456317","display_name":"Fixed-dose combination","level":2,"score":0.48009827733039856},{"id":"https://openalex.org/C2909086917","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol Fumarate","level":5,"score":0.4295642077922821},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3881269097328186},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.38338562846183777},{"id":"https://openalex.org/C2776954882","wikidata":"https://www.wikidata.org/wiki/Q840343","display_name":"Inhalation","level":2,"score":0.07703539729118347},{"id":"https://openalex.org/C2775859210","wikidata":"https://www.wikidata.org/wiki/Q26272","display_name":"Atropine","level":2,"score":0.055562347173690796},{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4455","doi":"https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4455","is_oa":false,"landing_page_url":"https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4455","pdf_url":null,"source":{"id":"https://openalex.org/S93356601","display_name":"American Journal of Respiratory and Critical Care Medicine","issn_l":"1073-449X","issn":["1073-449X","1535-4970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316311","host_organization_name":"American Thoracic Society","host_organization_lineage":["https://openalex.org/P4310316311"],"host_organization_lineage_names":["American Thoracic Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"C41. EMERGING PHARMACOLOGY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: MECHANISMS AND OUTCOMES","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W2077523026","https://openalex.org/W2127951128"],"related_works":["https://openalex.org/W2891812864","https://openalex.org/W2050417299","https://openalex.org/W2794357789","https://openalex.org/W2938293580","https://openalex.org/W2558903543","https://openalex.org/W2591678263","https://openalex.org/W7065364474","https://openalex.org/W2520775112","https://openalex.org/W2999792147","https://openalex.org/W2568255753"],"abstract_inverted_index":{"Rationale:":[0],"This":[1],"first-in-human":[2],"study":[3,73,102],"provided":[4],"safety":[5,77,217,261,282],"and":[6,18,46,59,78,132,174,188,257],"pharmacokinetic":[7],"(PK)":[8],"data":[9],"on":[10],"a":[11,95,108,129,159,260,278],"novel":[12,26,249],"fixed":[13,125,226,252],"dose":[14,22,43,227,253],"combination":[15,51,66,126,135,228,254],"of":[16,35,50,71,83,111,136,231,287],"Glycopyrrolate":[17],"Formoterol":[19],"Fumarate":[20],"metered":[21,42],"inhaler":[23,44],"(MDI).":[24],"Pearl\u2019s":[25],"porous":[27],"particle":[28],"based":[29],"suspension":[30],"technology":[31],"allows":[32],"better":[33],"targeting":[34],"drugs":[36],"to":[37,75,204,264],"the":[38,48,65,124,133,268,274],"airways":[39],"via":[40],"pressurized":[41],"(MDI),":[45],"enables":[47],"development":[49],"products":[52],"with":[53,89,208,259,267,292],"improved":[54],"physical":[55,186],"stability,":[56],"content":[57],"uniformity,":[58],"aerodynamic":[60],"size":[61],"distribution":[62],"similarity":[63],"across":[64],"drug":[67],"components.":[68],"The":[69,248],"objective":[70],"this":[72],"was":[74,94,158,255],"provide":[76],"PK":[79,189],"evidence":[80],"in":[81,87,103,229,234,290],"support":[82,284],"further":[84,285],"clinical":[85,178],"studies":[86],"patients":[88,291],"COPD.":[90,293],"Methods:":[91],"Study":[92],"PT0030901":[93],"randomized,":[96],"double-blind,":[97],"single-dose,":[98],"4-period":[99],"crossover,":[100],"single-center":[101],"healthy":[104],"subjects":[105,149,193,210],"that":[106,265],"evaluated":[107],"single":[109,130],"administration":[110],"4":[112],"inhaled":[113],"treatments:":[114],"glycopyrrolate":[115],"72":[116],"\u03bcg":[117,122],"(GP),":[118],"formoterol":[119],"fumarate":[120],"9.6":[121],"(FF),":[123],"GP/FF":[127,224,250,288],"from":[128,141],"MDI,":[131],"loose":[134,279],"GP":[137],"+":[138],"FF":[139],"administered":[140,270],"two":[142],"separate":[143],"MDIs.":[144],"At":[145],"each":[146],"treatment":[147,213],"visit,":[148],"were":[150,206,221],"assessed":[151],"for":[152,223],"12":[153],"hours":[154],"after":[155],"dosing.":[156],"There":[157],"minimum":[160],"7":[161],"day":[162],"washout":[163],"period":[164],"between":[165],"treatments.":[166],"Evaluations":[167],"included":[168],"adverse":[169],"events":[170],"(AEs),":[171],"dry":[172],"mouth":[173],"tremor":[175],"assessments,":[176],"hematology,":[177],"chemistry,":[179],"vital":[180,241],"signs,":[181,242],"12-lead":[182],"electrocardiograms":[183],"(ECG),":[184],"spirometry,":[185],"examinations,":[187],"parameters.":[190,246],"Results:":[191],"Sixteen":[192],"(11":[194],"females,":[195],"5":[196],"males),":[197],"average":[198],"age":[199],"27":[200],"years":[201],"(range":[202],"19":[203],"47),":[205],"enrolled":[207],"13":[209],"completing":[211],"all":[212],"periods.":[214],"No":[215],"important":[216],"trends":[218],"or":[219,237,244,272],"signals":[220],"noted":[222],"MDI":[225,251,289],"terms":[230],"AEs,":[232],"changes":[233],"serum":[235],"potassium":[236],"other":[238],"laboratory":[239],"values,":[240],"ECGs,":[243],"spirometry":[245],"Conclusions:":[247],"safe":[256],"well-tolerated,":[258],"profile":[262],"similar":[263],"observed":[266],"components":[269],"individually":[271],"at":[273],"same":[275],"time":[276],"as":[277],"combination.":[280],"These":[281],"findings":[283],"evaluation":[286]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2016-06-24T00:00:00"}